Global Parkinsons Disease Industry Key Trends, Size, Growth, Shares And Forecast Research Report 2016

Researchmoz added Most up-to-date research on "Global Parkinsons Disease Market Report: 2016 Edition" to its huge collection of research reports.

Parkinsons Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinsons primarily affects neurons in an area of the brain called the “substantia nigra”. The early signs and symptoms may be mild and may go unnoticed initially. The cause of this disease is mainly unknown with no cure till date but there exist several treatment options such as medications and surgery.

The current treatment market for Parkinsons disease has several unmet needs as no treatment has yet been successful in fully restoring the function that produces dopamine. However, the treatment currently only aims at controlling and relieving symptoms. The Parkinsons disease treatment market remains flooded by both branded and generic drugs. The market is expected to experience fluctuations in branded sales due to patent expiries and subsequent entry of generics in the market. Several biologics are under development for the treatment of Parkinsons along with possibility of developing “Stem Cell” as a treatment therapy.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=715352

The Parkinsons disease market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing healthcare expenditure and ageing population. The major growth drivers of the Parkinsons disease market includes rising level of toxin exposure, increasing life expectancy, rising male population worldwide, ageing population, healthcare expenditure and pesticide consumption. However, the growth of the market will also remain challenged by generic erosion, current treatment limitations and increasing risk of developing Melanoma.

The report, “Global Parkinsons disease Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S., the European Union and Japan are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Table of Content

1. Market Overview1.1 Introduction
1.2 Fundamental Features
1.3 Types of Parkinson’s Disease
1.4 Risk Factors
1.5 Treatment Options

2. Global Market
2.1 Global Parkinson’s Disease Drug Market by Value
2.1.1 Global Parkinson’s Disease Drug Market by Region
2.1.2 Global Parkinson’s Disease Market by Drug Class
2.1.3 Global Parkinson’s Disease Patient Population by Severity
2.1.4 Global Parkinson’s Disease Patient Population by Region

3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. Parkinson’s Disease Market by Value & Volume
3.1.2 The U.S. Parkinson’s Disease Market Value by Category
3.1.3 The U.S. Parkinson’s Disease Market Volume by Category
3.1.4 The U.S. Parkinson’s Disease Market by Drug Class
3.1.5 The U.S. Parkinson’s Disease Branded Drugs Market
3.1.6 The U.S. Parkinson’s Disease Generic Drugs Market
3.2 The European Union
3.2.1 The E.U. Parkinson’s Patient Prevalence & Diagnosis
3.2.2 The European Parkinson’s Disease Drug Market by Value
3.3 Japan
3.3.1 Japan’s Parkinson’s Disease Drug Market by Value

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Level of Toxin Exposure
4.1.2 Rising Life Expectancy
4.1.3 Rising Male Population
4.1.4 Increasing Ageing Population
4.1.5 Global Healthcare Expenditure
4.1.6 Pesticides Consumption
4.2 Trends
4.2.1 Late-Stage Drug Development for Parkinson’s Disease
4.2.2 Stem-Cell Therapy as Potential Treatment
4.2.3 Biologics under Development for Parkinson’s Disease
4.3 Challenges
4.3.1 Generic Erosion
4.3.2 Parkinson’s Treatment associated with Higher Risk of Melanoma
4.3.3 Current Treatment Limitation

5. Competitive Landscape
5.1 The U.S. Parkinson’s Disease Branded Drug Market by Company
5.2 The U.S. Parkinson’s Disease Generic Drug Market by Company

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=715352

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.